VITALHUB CORP (VHI.CA) Stock Fundamental Analysis
Canada - Toronto Stock Exchange - TSX:VHI - CA92847V5018 - Common Stock
8.79 CAD
-0.25 (-2.77%)
Overall VHI gets a fundamental rating of 6 out of 10. We evaluated VHI against 9 industry peers in the Health Care Technology industry. VHI has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. VHI is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings would make VHI suitable for growth and quality investing!
1. Profitability
1.1 Basic Checks
- VHI had positive earnings in the past year.
- In the past year VHI had a positive cash flow from operations.
- In multiple years VHI reported negative net income over the last 5 years.
- VHI had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- With an excellent Return On Assets value of 0.76%, VHI belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
- VHI has a Return On Equity of 1.08%. This is amongst the best in the industry. VHI outperforms 88.89% of its industry peers.
- Looking at the Return On Invested Capital, with a value of 2.86%, VHI belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
- VHI had an Average Return On Invested Capital over the past 3 years of 3.96%. This is in line with the industry average of 2.16%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.76% | ||
| ROE | 1.08% | ||
| ROIC | 2.86% |
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
1.3 Margins
- Looking at the Profit Margin, with a value of 2.88%, VHI belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
- Looking at the Operating Margin, with a value of 12.47%, VHI belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
- In the last couple of years the Operating Margin of VHI has grown nicely.
- Looking at the Gross Margin, with a value of 80.92%, VHI belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
- VHI's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.47% | ||
| PM (TTM) | 2.88% | ||
| GM | 80.92% |
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
2. Health
2.1 Basic Checks
- VHI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- VHI has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, VHI has more shares outstanding
- The debt/assets ratio for VHI has been reduced compared to a year ago.
2.2 Solvency
- An Altman-Z score of 3.72 indicates that VHI is not in any danger for bankruptcy at the moment.
- The Altman-Z score of VHI (3.72) is comparable to the rest of the industry.
- VHI has a debt to FCF ratio of 0.13. This is a very positive value and a sign of high solvency as it would only need 0.13 years to pay back of all of its debts.
- VHI's Debt to FCF ratio of 0.13 is amongst the best of the industry. VHI outperforms 100.00% of its industry peers.
- VHI has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
- VHI has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. VHI outperforms 88.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.13 | ||
| Altman-Z | 3.72 |
ROIC/WACC0.33
WACC8.65%
2.3 Liquidity
- VHI has a Current Ratio of 1.94. This is a normal value and indicates that VHI is financially healthy and should not expect problems in meeting its short term obligations.
- VHI's Current ratio of 1.94 is fine compared to the rest of the industry. VHI outperforms 77.78% of its industry peers.
- VHI has a Quick Ratio of 1.94. This is a normal value and indicates that VHI is financially healthy and should not expect problems in meeting its short term obligations.
- VHI has a Quick ratio of 1.94. This is in the better half of the industry: VHI outperforms 77.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.94 | ||
| Quick Ratio | 1.94 |
3. Growth
3.1 Past
- VHI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -14.29%.
- VHI shows a strong growth in Revenue. In the last year, the Revenue has grown by 59.34%.
- VHI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 46.32% yearly.
EPS 1Y (TTM)-14.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
Revenue 1Y (TTM)59.34%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%94.1%
3.2 Future
- The Earnings Per Share is expected to grow by 70.74% on average over the next years. This is a very strong growth
- The Revenue is expected to grow by 27.33% on average over the next years. This is a very strong growth
EPS Next Y-6.21%
EPS Next 2Y86.09%
EPS Next 3Y70.74%
EPS Next 5YN/A
Revenue Next Year60.05%
Revenue Next 2Y38.57%
Revenue Next 3Y27.33%
Revenue Next 5YN/A
3.3 Evolution
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 146.50, VHI can be considered very expensive at the moment.
- Compared to the rest of the industry, the Price/Earnings ratio of VHI indicates a rather cheap valuation: VHI is cheaper than 100.00% of the companies listed in the same industry.
- VHI's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.54.
- VHI is valuated quite expensively with a Price/Forward Earnings ratio of 36.26.
- Based on the Price/Forward Earnings ratio, VHI is valued cheaper than 88.89% of the companies in the same industry.
- VHI's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 24.31.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 146.5 | ||
| Fwd PE | 36.26 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, VHI is valued cheaper than 100.00% of the companies in the same industry.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of VHI indicates a rather cheap valuation: VHI is cheaper than 100.00% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 45.54 | ||
| EV/EBITDA | 19.82 |
4.3 Compensation for Growth
- The decent profitability rating of VHI may justify a higher PE ratio.
- VHI's earnings are expected to grow with 70.74% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y86.09%
EPS Next 3Y70.74%
5. Dividend
5.1 Amount
- VHI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
TSX:VHI (1/14/2026, 7:00:00 PM)
8.79
-0.25 (-2.77%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)03-16 2026-03-16
Inst Owners40.16%
Inst Owner ChangeN/A
Ins Owners11.45%
Ins Owner ChangeN/A
Market Cap554.82M
Revenue(TTM)98.17M
Net Income(TTM)2.83M
Analysts81.33
Price Target15.51 (76.45%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-78.71%
Min EPS beat(2)-129.12%
Max EPS beat(2)-28.31%
EPS beat(4)0
Avg EPS beat(4)-61.43%
Min EPS beat(4)-129.12%
Max EPS beat(4)-28.31%
EPS beat(8)0
Avg EPS beat(8)-58.34%
EPS beat(12)1
Avg EPS beat(12)-46.79%
EPS beat(16)2
Avg EPS beat(16)-54.73%
Revenue beat(2)2
Avg Revenue beat(2)9.95%
Min Revenue beat(2)7.24%
Max Revenue beat(2)12.66%
Revenue beat(4)4
Avg Revenue beat(4)6.3%
Min Revenue beat(4)0.61%
Max Revenue beat(4)12.66%
Revenue beat(8)6
Avg Revenue beat(8)4.15%
Revenue beat(12)10
Avg Revenue beat(12)4.05%
Revenue beat(16)12
Avg Revenue beat(16)4.16%
PT rev (1m)0%
PT rev (3m)-1.75%
EPS NQ rev (1m)-25%
EPS NQ rev (3m)-41.67%
EPS NY rev (1m)-4.1%
EPS NY rev (3m)-44.09%
Revenue NQ rev (1m)0.57%
Revenue NQ rev (3m)4.7%
Revenue NY rev (1m)0.42%
Revenue NY rev (3m)4.24%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 146.5 | ||
| Fwd PE | 36.26 | ||
| P/S | 5.65 | ||
| P/FCF | 45.54 | ||
| P/OCF | 42.95 | ||
| P/B | 2.12 | ||
| P/tB | 11.27 | ||
| EV/EBITDA | 19.82 |
EPS(TTM)0.06
EY0.68%
EPS(NY)0.24
Fwd EY2.76%
FCF(TTM)0.19
FCFY2.2%
OCF(TTM)0.2
OCFY2.33%
SpS1.56
BVpS4.15
TBVpS0.78
PEG (NY)N/A
PEG (5Y)N/A
Graham Number2.37
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.76% | ||
| ROE | 1.08% | ||
| ROCE | 4.19% | ||
| ROIC | 2.86% | ||
| ROICexc | 4.95% | ||
| ROICexgc | N/A | ||
| OM | 12.47% | ||
| PM (TTM) | 2.88% | ||
| GM | 80.92% | ||
| FCFM | 12.41% |
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
ROICexc(3y)5.88%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)5.82%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y132.1%
ROICexc growth 5YN/A
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
F-Score3
Asset Turnover0.27
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.13 | ||
| Debt/EBITDA | 0.05 | ||
| Cap/Depr | 7.67% | ||
| Cap/Sales | 0.75% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 59.17% | ||
| Profit Quality | 430.43% | ||
| Current Ratio | 1.94 | ||
| Quick Ratio | 1.94 | ||
| Altman-Z | 3.72 |
F-Score3
WACC8.65%
ROIC/WACC0.33
Cap/Depr(3y)9.42%
Cap/Depr(5y)8.61%
Cap/Sales(3y)0.86%
Cap/Sales(5y)0.89%
Profit Quality(3y)466.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
EPS Next Y-6.21%
EPS Next 2Y86.09%
EPS Next 3Y70.74%
EPS Next 5YN/A
Revenue 1Y (TTM)59.34%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%94.1%
Revenue Next Year60.05%
Revenue Next 2Y38.57%
Revenue Next 3Y27.33%
Revenue Next 5YN/A
EBIT growth 1Y46.83%
EBIT growth 3Y217.15%
EBIT growth 5YN/A
EBIT Next Year76.68%
EBIT Next 3Y40.05%
EBIT Next 5YN/A
FCF growth 1Y-12.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-10.32%
OCF growth 3YN/A
OCF growth 5YN/A
VITALHUB CORP / VHI.CA FAQ
What is the fundamental rating for VHI stock?
ChartMill assigns a fundamental rating of 6 / 10 to VHI.CA.
What is the valuation status of VITALHUB CORP (VHI.CA) stock?
ChartMill assigns a valuation rating of 5 / 10 to VITALHUB CORP (VHI.CA). This can be considered as Fairly Valued.
Can you provide the profitability details for VITALHUB CORP?
VITALHUB CORP (VHI.CA) has a profitability rating of 7 / 10.
Can you provide the financial health for VHI stock?
The financial health rating of VITALHUB CORP (VHI.CA) is 7 / 10.